Seeking Alpha

Oppenheimer recommends Express Scripts (ESRX) shares even if regulators shoot down the planned...

Oppenheimer recommends Express Scripts (ESRX) shares even if regulators shoot down the planned acquisition of Medco (MHS). Already a valuation opportunity, if the buyout fails, Medco would be badly weakened after client losses and months of limbo. If the deal closes, ESRX would be left as the only major independent pharmacy benefits manager.
Comments (1)
  • Drew Robertson
    , contributor
    Comments (347) | Send Message
     
    Sounds like what AT&T is going to do to T-Mobile.
    4 Oct 2011, 12:01 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs